You've used all available free searches this month | for more free features.
Clincosm LogoSign in Get a demo

natural-killer group 2, member D receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Metastatic Colorectal Cancer Trial in Hangzhou (NKG2D CAR-NK)

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • NKG2D CAR-NK
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University
Jan 16, 2022

Refractory Metastatic Colorectal Cancer Trial in Guangzhou (CAR-T infusion)

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • CAR-T infusion
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Guangzhou Medical University
Feb 9, 2022

Advanced Solid Tumors Trial in Hangzhou (Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT))

Recruiting
  • Advanced Solid Tumors
  • Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT)
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Aug 3, 2023

Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])

Not yet recruiting
  • Acute Myeloid Leukemia
  • NK cells
  • Talazoparib 1 MG [Talzenna]
  • (no location specified)
Jan 9, 2023

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Recruiting
  • Colorectal Cancer
  • +11 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023

Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

Recruiting
  • Recurrent Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Neuroblastoma
  • GINAKIT Cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Jan 18, 2023

Breast Tumors Trial in Barcelona (Cyclophosphamide, Trastuzumab, Pertuzumab)

Recruiting
  • Breast Neoplasms
  • Barcelona, Spain
  • +1 more
May 31, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 28, 2022

Multiple Myeloma Trial in New York (Infusion of MCARH109 T cells)

Active, not recruiting
  • Multiple Myeloma
  • Infusion of MCARH109 T cells
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 5, 2022

Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma Trial in Houston (Cord Blood-derived

Not yet recruiting
  • Recurrent Gliosarcoma
  • +2 more
  • Cord Blood-derived Expanded Allogeneic Natural Killer Cells
  • Resection
  • Houston, Texas
    M D Anderson Cancer Center
May 24, 2022

AML Trial in Hangzhou (NKG2D CAR-NK)

Recruiting
  • AML
  • NKG2D CAR-NK
  • Hangzhou, Zhejiang, China
  • +1 more
Feb 17, 2023

Patients With Peroxisome Biogenesis Disorders (PBD)

Recruiting
  • Peroxisome Biogenesis Disorder
  • +10 more
    • Montreal, Quebec, Canada
      Research Institute of the McGill University Health Center
    Jul 4, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +14 more
    • Aldesleukin
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

    Not yet recruiting
    • NHL, Relapsed, Adult
    • +3 more
    • KUR-502
    • (no location specified)
    Aug 2, 2022

    Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (drug, biological, other)

    Completed
    • Recurrent Adult Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 18, 2021

    Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)

    Completed
    • Mantle Cell Lymphoma
    • +6 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 18, 2022

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Orange City, Florida
    • +27 more
    Jul 19, 2023

    Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )

    Completed
    Has Results
    • Pancreatic Cancer
    • +4 more
    • Scottsdale, Arizona
    • +5 more
    Dec 1, 2022

    Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Tumor Trial in Houston

    Recruiting
    • Recurrent Cutaneous Melanoma
    • +27 more
    • Cord Blood-derived Expanded Allogeneic Natural Killer Cells
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 28, 2021

    Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

    Recruiting
    • Neuroblastoma Recurrent
    • Natural killer cell
    • +4 more
    • Hong Kong, Hong Kong
      Hong Kong Children's Hospital
    Feb 22, 2023

    Hepatocellular Carcinoma Trial in Jakarta Pusat (Autologous Natural Killer Cell Therapy, Clinimacs Plus)

    Recruiting
    • Hepatocellular Carcinoma
    • Autologous Natural Killer Cell Therapy
    • Clinimacs Plus
    • Jakarta Pusat, Jakarta, Indonesia
      Cipto Mangunkusumo General Hospital
    Sep 24, 2023

    Merkel Cell Carcinoma Trial in United States (Avelumab, N-803, haNK™)

    Terminated
    • Merkel Cell Carcinoma
    • Avelumab
    • +2 more
    • San Francisco, California
    • +4 more
    Jan 7, 2022

    Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

    Active, not recruiting
    • Breast Cancer
    • Atlanta, Georgia
    • +19 more
    Dec 5, 2022

    Interleukin-6 Inhibition, Physical Stress, Appetitive Behavior Trial in Copenhagen Ø (Tocilizumab Injectable Product, Saline

    Completed
    • Interleukin-6 Inhibition
    • +2 more
    • Tocilizumab Injectable Product
    • Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour
    • Copenhagen Ø, Denmark
      Center For Physical Activity (CFAS)
    Aug 19, 2022